ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,995Medicare Part D Prescriptions Filled, Including Refills

Rank: 292 out of 1454

$660K Total Retail Price of All Prescriptions

Rank: 261 out of 1454

465 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 465 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 465 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,254 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
HYDROCODONE-ACETAMINOPHEN 376 254 S3 1 7
LEVOTHYROXINE SODIUM 359 321 2 5
AMLODIPINE BESYLATE 348 314 3 2
OMEPRAZOLE 340 317 4 3
METFORMIN HCL 303 281 5 8
SIMVASTATIN 215 215 6 1
TRAMADOL HCL 207 193 7 20
FUROSEMIDE 207 156 7 6
ZOLPIDEM TARTRATE 191 163 9 19
LOSARTAN POTASSIUM 189 173 10 14
CARVEDILOL 163 138 11 24
GLIMEPIRIDE 150 129 12 33
METOPROLOL TARTRATE 149 148 13 10
DONEPEZIL HCL 141 141 14 29
SYNTHROID 141 129 14 25
RANITIDINE HCL 137 112 16 43
PREDNISONE 135 107 17 36
LOVASTATIN 130 130 18 39
GABAPENTIN 125 107 19 16
ATORVASTATIN CALCIUM 122 118 20 11
NEXIUM 120 95 21 23
PANTOPRAZOLE SODIUM 110 96 22 31
CITALOPRAM HBR 109 86 23 21
VERAPAMIL ER 108 107 24 89
KLOR-CON M20 107 76 25 54
HYDROCHLOROTHIAZIDE 107 103 25 9
TRIAMTERENE-HCTZ 106 90 27 44
METOPROLOL SUCCINATE 98 85 28 13
SPIRONOLACTONE 96 85 29 63
MELOXICAM 94 76 30 37
CIPROFLOXACIN HCL 92 74 31 64
AZITHROMYCIN 91 75 32 42
PAROXETINE HCL 90 85 33 73
ATENOLOL 89 88 34 18
FLUTICASONE PROPIONATE 84 72 35 30
CRESTOR 83 83 36 22
FLUOXETINE HCL 81 66 37 72
IBUPROFEN 80 72 38 107
LOSARTAN-HYDROCHLOROTHIAZIDE 78 74 39 38
PROPRANOLOL HCL 77 56 40 129
BENAZEPRIL HCL 75 58 41 57
ALLOPURINOL 72 66 42 28
NAMENDA 72 72 42 48
WARFARIN SODIUM 69 63 44 17
DIOVAN 65 58 45 40
CYCLOBENZAPRINE HCL 64 32 R 46 59
TRIAMCINOLONE ACETONIDE 64 57 46 142
LISINOPRIL 64 64 46 4
TRAZODONE HCL 58 29 49 50
PRAVASTATIN SODIUM 57 57 50 12
ENALAPRIL MALEATE 54 52 51 58
PROMETHAZINE HCL 53 31 R 52 82
PROAIR HFA 51 42 53 56
CALCITRIOL 50 36 54 256
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.